aluates Reports

$ 0.0

Automative

Global Nuclear Medicine Market Research Report 2026

Published Date: 2026-02-05

Report Code: QYRE-Auto-3I2814

Global Nuclear Medicine Market Insights and Forecast to 2028

BUY CHAPTERS

Global Nuclear Medicine Market Research Report 2026

Code: QYRE-Auto-3I2814

Report

2026-02-05

Pages:111

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

GE Healthcare

Bracco Imaging

Bayer

Jubilant Pharma

Eli Lilly

Siemens AG

China Isotope & Radiation

Cardinal Health

Novartis

Curium Pharma

Lantheus

Aurobindo Pharma

Mundipharma

Yantai Dongcheng

China Isotope & Radiation

Nuclear Medicine Market Size

The global Nuclear Medicine market was valued at US$ 7224 million in 2025 and is anticipated to reach US$ 11830 million by 2032, at a CAGR of 7.4% from 2026 to 2032.

Nuclear Medicine Market

Nuclear Medicine，or Radiopharmaceuticals， are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.

Market Drivers

The nuclear medicine market is experiencing significant growth due to the increasing prevalence of chronic diseases, including cancer, cardiovascular diseases, and neurological disorders, which require advanced diagnostic and therapeutic solutions. Nuclear medicine provides highly targeted treatment, such as radioisotope therapy, and is crucial for precise imaging techniques like PET and SPECT, which offer better disease detection and management. Advances in radiopharmaceuticals, such as the development of new radioisotopes, and the rising demand for personalized medicine further fuel the market's expansion. Additionally, the growing emphasis on early diagnosis and treatment monitoring in healthcare systems, along with the availability of funding for research and development in nuclear medicine, contributes to market growth.

Market Challenges

Despite its advantages, the nuclear medicine market faces challenges related to the high costs of nuclear medicine treatments and imaging technologies. The infrastructure required for nuclear medicine, including specialized facilities, trained professionals, and the availability of radiopharmaceuticals, can be prohibitively expensive, especially in developing regions. Additionally, concerns over the safe handling and disposal of radioactive materials, regulatory hurdles, and the relatively short half-life of certain isotopes create logistical difficulties in terms of production, distribution, and patient access. These challenges can limit the widespread adoption of nuclear medicine, particularly in low-resource healthcare settings.

This report delivers a comprehensive overview of the global Nuclear Medicine market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Nuclear Medicine. The Nuclear Medicine market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Nuclear Medicine market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Nuclear Medicine manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Nuclear Medicine Market Report

Report Metric	Details
Report Name	Nuclear Medicine Market
Accounted market size in 2025	US$ 7224 million
Forecasted market size in 2032	US$ 11830 million
CAGR	7.4%
Base Year	2025
Forecasted years	2026 - 2032
Segment by Type	Diagnostic Nuclear Medicine Therapeutic Nuclear Medicine
Segment by Application	Oncology Thyroid Cardiology Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Cardinal Health, GE Healthcare, Jubilant Pharma, Novartis, Curium Pharma, SIEMENS, Lantheus, Bracco Imaging, Bayer, Eli Lilly, Aurobindo Pharma, Mundipharma, China Isotope & Radiation, Yantai Dongcheng
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Nuclear Medicine companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.

FAQ for this report

How fast is Nuclear Medicine Market growing?

Ans: The Nuclear Medicine Market witnessing a CAGR of 7.4% during the forecast period 2026-2032.

What is the Nuclear Medicine Market size in 2032?

Ans: The Nuclear Medicine Market size in 2032 will be US$ 11830 million.

Who are the main players in the Nuclear Medicine Market report?

Ans: The main players in the Nuclear Medicine Market are Cardinal Health, GE Healthcare, Jubilant Pharma, Novartis, Curium Pharma, SIEMENS, Lantheus, Bracco Imaging, Bayer, Eli Lilly, Aurobindo Pharma, Mundipharma, China Isotope & Radiation, Yantai Dongcheng

What are the Application segmentation covered in the Nuclear Medicine Market report?

Ans: The Applications covered in the Nuclear Medicine Market report are Oncology, Thyroid, Cardiology, Others

What are the Type segmentation covered in the Nuclear Medicine Market report?

Ans: The Types covered in the Nuclear Medicine Market report are Diagnostic Nuclear Medicine, Therapeutic Nuclear Medicine

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Nuclear Medicine Market Size Growth Rate by Type: 2021 vs 2025 vs 2032

1.2.2 Diagnostic Nuclear Medicine

1.2.3 Therapeutic Nuclear Medicine

1.3 Market by Application

1.3.1 Global Nuclear Medicine Market Growth by Application: 2021 vs 2025 vs 2032

1.3.2 Oncology

1.3.3 Thyroid

1.3.4 Cardiology

1.3.5 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Nuclear Medicine Market Perspective (2021–2032)

2.2 Global Nuclear Medicine Growth Trends by Region

2.2.1 Global Nuclear Medicine Market Size by Region: 2021 vs 2025 vs 2032

2.2.2 Nuclear Medicine Historic Market Size by Region (2021–2026)

2.2.3 Nuclear Medicine Forecasted Market Size by Region (2027–2032)

2.3 Nuclear Medicine Market Dynamics

2.3.1 Nuclear Medicine Industry Trends

2.3.2 Nuclear Medicine Market Drivers

2.3.3 Nuclear Medicine Market Challenges

2.3.4 Nuclear Medicine Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Nuclear Medicine Players by Revenue

3.1.1 Global Top Nuclear Medicine Players by Revenue (2021–2026)

3.1.2 Global Nuclear Medicine Revenue Market Share by Players (2021–2026)

3.2 Global Top Nuclear Medicine Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

3.3 Global Key Players Ranking by Nuclear Medicine Revenue

3.4 Global Nuclear Medicine Market Concentration Ratio

3.4.1 Global Nuclear Medicine Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Nuclear Medicine Revenue in 2025

3.5 Global Key Players of Nuclear Medicine Head Offices and Areas Served

3.6 Global Key Players of Nuclear Medicine, Products and Applications

3.7 Global Key Players of Nuclear Medicine, Date of General Availability (GA)

3.8 Mergers and Acquisitions, Expansion Plans

4 Nuclear Medicine Breakdown Data by Type

4.1 Global Nuclear Medicine Historic Market Size by Type (2021–2026)

4.2 Global Nuclear Medicine Forecasted Market Size by Type (2027–2032)

5 Nuclear Medicine Breakdown Data by Application

5.1 Global Nuclear Medicine Historic Market Size by Application (2021–2026)

5.2 Global Nuclear Medicine Forecasted Market Size by Application (2027–2032)

6 North America

6.1 North America Nuclear Medicine Market Size (2021–2032)

6.2 North America Nuclear Medicine Market Growth Rate by Country: 2021 vs 2025 vs 2032

6.3 North America Nuclear Medicine Market Size by Country (2021–2026)

6.4 North America Nuclear Medicine Market Size by Country (2027–2032)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Nuclear Medicine Market Size (2021–2032)

7.2 Europe Nuclear Medicine Market Growth Rate by Country: 2021 vs 2025 vs 2032

7.3 Europe Nuclear Medicine Market Size by Country (2021–2026)

7.4 Europe Nuclear Medicine Market Size by Country (2027–2032)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific Nuclear Medicine Market Size (2021–2032)

8.2 Asia-Pacific Nuclear Medicine Market Growth Rate by Region: 2021 vs 2025 vs 2032

8.3 Asia-Pacific Nuclear Medicine Market Size by Region (2021–2026)

8.4 Asia-Pacific Nuclear Medicine Market Size by Region (2027–2032)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America Nuclear Medicine Market Size (2021–2032)

9.2 Latin America Nuclear Medicine Market Growth Rate by Country: 2021 vs 2025 vs 2032

9.3 Latin America Nuclear Medicine Market Size by Country (2021–2026)

9.4 Latin America Nuclear Medicine Market Size by Country (2027–2032)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Nuclear Medicine Market Size (2021–2032)

10.2 Middle East & Africa Nuclear Medicine Market Growth Rate by Country: 2021 vs 2025 vs 2032

10.3 Middle East & Africa Nuclear Medicine Market Size by Country (2021–2026)

10.4 Middle East & Africa Nuclear Medicine Market Size by Country (2027–2032)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Cardinal Health

11.1.1 Cardinal Health Company Details

11.1.2 Cardinal Health Business Overview

11.1.3 Cardinal Health Nuclear Medicine Introduction

11.1.4 Cardinal Health Revenue in Nuclear Medicine Business (2021–2026)

11.1.5 Cardinal Health Recent Development

11.2 GE Healthcare

11.2.1 GE Healthcare Company Details

11.2.2 GE Healthcare Business Overview

11.2.3 GE Healthcare Nuclear Medicine Introduction

11.2.4 GE Healthcare Revenue in Nuclear Medicine Business (2021–2026)

11.2.5 GE Healthcare Recent Development

11.3 Jubilant Pharma

11.3.1 Jubilant Pharma Company Details

11.3.2 Jubilant Pharma Business Overview

11.3.3 Jubilant Pharma Nuclear Medicine Introduction

11.3.4 Jubilant Pharma Revenue in Nuclear Medicine Business (2021–2026)

11.3.5 Jubilant Pharma Recent Development

11.4 Novartis

11.4.1 Novartis Company Details

11.4.2 Novartis Business Overview

11.4.3 Novartis Nuclear Medicine Introduction

11.4.4 Novartis Revenue in Nuclear Medicine Business (2021–2026)

11.4.5 Novartis Recent Development

11.5 Curium Pharma

11.5.1 Curium Pharma Company Details

11.5.2 Curium Pharma Business Overview

11.5.3 Curium Pharma Nuclear Medicine Introduction

11.5.4 Curium Pharma Revenue in Nuclear Medicine Business (2021–2026)

11.5.5 Curium Pharma Recent Development

11.6 SIEMENS

11.6.1 SIEMENS Company Details

11.6.2 SIEMENS Business Overview

11.6.3 SIEMENS Nuclear Medicine Introduction

11.6.4 SIEMENS Revenue in Nuclear Medicine Business (2021–2026)

11.6.5 SIEMENS Recent Development

11.7 Lantheus

11.7.1 Lantheus Company Details

11.7.2 Lantheus Business Overview

11.7.3 Lantheus Nuclear Medicine Introduction

11.7.4 Lantheus Revenue in Nuclear Medicine Business (2021–2026)

11.7.5 Lantheus Recent Development

11.8 Bracco Imaging

11.8.1 Bracco Imaging Company Details

11.8.2 Bracco Imaging Business Overview

11.8.3 Bracco Imaging Nuclear Medicine Introduction

11.8.4 Bracco Imaging Revenue in Nuclear Medicine Business (2021–2026)

11.8.5 Bracco Imaging Recent Development

11.9 Bayer

11.9.1 Bayer Company Details

11.9.2 Bayer Business Overview

11.9.3 Bayer Nuclear Medicine Introduction

11.9.4 Bayer Revenue in Nuclear Medicine Business (2021–2026)

11.9.5 Bayer Recent Development

11.10 Eli Lilly

11.10.1 Eli Lilly Company Details

11.10.2 Eli Lilly Business Overview

11.10.3 Eli Lilly Nuclear Medicine Introduction

11.10.4 Eli Lilly Revenue in Nuclear Medicine Business (2021–2026)

11.10.5 Eli Lilly Recent Development

11.11 Aurobindo Pharma

11.11.1 Aurobindo Pharma Company Details

11.11.2 Aurobindo Pharma Business Overview

11.11.3 Aurobindo Pharma Nuclear Medicine Introduction

11.11.4 Aurobindo Pharma Revenue in Nuclear Medicine Business (2021–2026)

11.11.5 Aurobindo Pharma Recent Development

11.12 Mundipharma

11.12.1 Mundipharma Company Details

11.12.2 Mundipharma Business Overview

11.12.3 Mundipharma Nuclear Medicine Introduction

11.12.4 Mundipharma Revenue in Nuclear Medicine Business (2021–2026)

11.12.5 Mundipharma Recent Development

11.13 China Isotope & Radiation

11.13.1 China Isotope & Radiation Company Details

11.13.2 China Isotope & Radiation Business Overview

11.13.3 China Isotope & Radiation Nuclear Medicine Introduction

11.13.4 China Isotope & Radiation Revenue in Nuclear Medicine Business (2021–2026)

11.13.5 China Isotope & Radiation Recent Development

11.14 Yantai Dongcheng

11.14.1 Yantai Dongcheng Company Details

11.14.2 Yantai Dongcheng Business Overview

11.14.3 Yantai Dongcheng Nuclear Medicine Introduction

11.14.4 Yantai Dongcheng Revenue in Nuclear Medicine Business (2021–2026)

11.14.5 Yantai Dongcheng Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

GE Healthcare

Bracco Imaging

Bayer

Jubilant Pharma

Eli Lilly

Siemens AG

China Isotope & Radiation

Cardinal Health

Novartis

Curium Pharma

Lantheus

Aurobindo Pharma

Mundipharma

Yantai Dongcheng

China Isotope & Radiation

List of Tables

Table 1. Global Nuclear Medicine Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032

Table 2. Key Players of Diagnostic Nuclear Medicine

Table 3. Key Players of Therapeutic Nuclear Medicine

Table 4. Global Nuclear Medicine Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032

Table 5. Global Nuclear Medicine Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 6. Global Nuclear Medicine Market Size by Region (US$ Million), 2021–2026

Table 7. Global Nuclear Medicine Market Share by Region (2021–2026)

Table 8. Global Nuclear Medicine Forecasted Market Size by Region (US$ Million), 2027–2032

Table 9. Global Nuclear Medicine Market Share by Region (2027–2032)

Table 10. Nuclear Medicine Market Trends

Table 11. Nuclear Medicine Market Drivers

Table 12. Nuclear Medicine Market Challenges

Table 13. Nuclear Medicine Market Restraints

Table 14. Global Nuclear Medicine Revenue by Players (US$ Million), 2021–2026

Table 15. Global Nuclear Medicine Market Share by Players (2021–2026)

Table 16. Global Top Nuclear Medicine Players by Tier (Tier 1, Tier 2, and Tier 3), based on Nuclear Medicine Revenue, 2025

Table 17. Ranking of Global Top Nuclear Medicine Companies by Revenue (US$ Million) in 2025

Table 18. Global 5 Largest Players Market Share by Nuclear Medicine Revenue (CR5 and HHI), 2021–2026

Table 19. Global Key Players of Nuclear Medicine, Headquarters and Area Served

Table 20. Global Key Players of Nuclear Medicine, Products and Applications

Table 21. Global Key Players of Nuclear Medicine, Date of General Availability (GA)

Table 22. Mergers and Acquisitions, Expansion Plans

Table 23. Global Nuclear Medicine Market Size by Type (US$ Million), 2021–2026

Table 24. Global Nuclear Medicine Revenue Market Share by Type (2021–2026)

Table 25. Global Nuclear Medicine Forecasted Market Size by Type (US$ Million), 2027–2032

Table 26. Global Nuclear Medicine Revenue Market Share by Type (2027–2032)

Table 27. Global Nuclear Medicine Market Size by Application (US$ Million), 2021–2026

Table 28. Global Nuclear Medicine Revenue Market Share by Application (2021–2026)

Table 29. Global Nuclear Medicine Forecasted Market Size by Application (US$ Million), 2027–2032

Table 30. Global Nuclear Medicine Revenue Market Share by Application (2027–2032)

Table 31. North America Nuclear Medicine Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 32. North America Nuclear Medicine Market Size by Country (US$ Million), 2021–2026

Table 33. North America Nuclear Medicine Market Size by Country (US$ Million), 2027–2032

Table 34. Europe Nuclear Medicine Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 35. Europe Nuclear Medicine Market Size by Country (US$ Million), 2021–2026

Table 36. Europe Nuclear Medicine Market Size by Country (US$ Million), 2027–2032

Table 37. Asia-Pacific Nuclear Medicine Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032

Table 38. Asia-Pacific Nuclear Medicine Market Size by Region (US$ Million), 2021–2026

Table 39. Asia-Pacific Nuclear Medicine Market Size by Region (US$ Million), 2027–2032

Table 40. Latin America Nuclear Medicine Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 41. Latin America Nuclear Medicine Market Size by Country (US$ Million), 2021–2026

Table 42. Latin America Nuclear Medicine Market Size by Country (US$ Million), 2027–2032

Table 43. Middle East & Africa Nuclear Medicine Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 44. Middle East & Africa Nuclear Medicine Market Size by Country (US$ Million), 2021–2026

Table 45. Middle East & Africa Nuclear Medicine Market Size by Country (US$ Million), 2027–2032

Table 46. Cardinal Health Company Details

Table 47. Cardinal Health Business Overview

Table 48. Cardinal Health Nuclear Medicine Product

Table 49. Cardinal Health Revenue in Nuclear Medicine Business (US$ Million), 2021–2026

Table 50. Cardinal Health Recent Development

Table 51. GE Healthcare Company Details

Table 52. GE Healthcare Business Overview

Table 53. GE Healthcare Nuclear Medicine Product

Table 54. GE Healthcare Revenue in Nuclear Medicine Business (US$ Million), 2021–2026

Table 55. GE Healthcare Recent Development

Table 56. Jubilant Pharma Company Details

Table 57. Jubilant Pharma Business Overview

Table 58. Jubilant Pharma Nuclear Medicine Product

Table 59. Jubilant Pharma Revenue in Nuclear Medicine Business (US$ Million), 2021–2026

Table 60. Jubilant Pharma Recent Development

Table 61. Novartis Company Details

Table 62. Novartis Business Overview

Table 63. Novartis Nuclear Medicine Product

Table 64. Novartis Revenue in Nuclear Medicine Business (US$ Million), 2021–2026

Table 65. Novartis Recent Development

Table 66. Curium Pharma Company Details

Table 67. Curium Pharma Business Overview

Table 68. Curium Pharma Nuclear Medicine Product

Table 69. Curium Pharma Revenue in Nuclear Medicine Business (US$ Million), 2021–2026

Table 70. Curium Pharma Recent Development

Table 71. SIEMENS Company Details

Table 72. SIEMENS Business Overview

Table 73. SIEMENS Nuclear Medicine Product

Table 74. SIEMENS Revenue in Nuclear Medicine Business (US$ Million), 2021–2026

Table 75. SIEMENS Recent Development

Table 76. Lantheus Company Details

Table 77. Lantheus Business Overview

Table 78. Lantheus Nuclear Medicine Product

Table 79. Lantheus Revenue in Nuclear Medicine Business (US$ Million), 2021–2026

Table 80. Lantheus Recent Development

Table 81. Bracco Imaging Company Details

Table 82. Bracco Imaging Business Overview

Table 83. Bracco Imaging Nuclear Medicine Product

Table 84. Bracco Imaging Revenue in Nuclear Medicine Business (US$ Million), 2021–2026

Table 85. Bracco Imaging Recent Development

Table 86. Bayer Company Details

Table 87. Bayer Business Overview

Table 88. Bayer Nuclear Medicine Product

Table 89. Bayer Revenue in Nuclear Medicine Business (US$ Million), 2021–2026

Table 90. Bayer Recent Development

Table 91. Eli Lilly Company Details

Table 92. Eli Lilly Business Overview

Table 93. Eli Lilly Nuclear Medicine Product

Table 94. Eli Lilly Revenue in Nuclear Medicine Business (US$ Million), 2021–2026

Table 95. Eli Lilly Recent Development

Table 96. Aurobindo Pharma Company Details

Table 97. Aurobindo Pharma Business Overview

Table 98. Aurobindo Pharma Nuclear Medicine Product

Table 99. Aurobindo Pharma Revenue in Nuclear Medicine Business (US$ Million), 2021–2026

Table 100. Aurobindo Pharma Recent Development

Table 101. Mundipharma Company Details

Table 102. Mundipharma Business Overview

Table 103. Mundipharma Nuclear Medicine Product

Table 104. Mundipharma Revenue in Nuclear Medicine Business (US$ Million), 2021–2026

Table 105. Mundipharma Recent Development

Table 106. China Isotope & Radiation Company Details

Table 107. China Isotope & Radiation Business Overview

Table 108. China Isotope & Radiation Nuclear Medicine Product

Table 109. China Isotope & Radiation Revenue in Nuclear Medicine Business (US$ Million), 2021–2026

Table 110. China Isotope & Radiation Recent Development

Table 111. Yantai Dongcheng Company Details

Table 112. Yantai Dongcheng Business Overview

Table 113. Yantai Dongcheng Nuclear Medicine Product

Table 114. Yantai Dongcheng Revenue in Nuclear Medicine Business (US$ Million), 2021–2026

Table 115. Yantai Dongcheng Recent Development

Table 116. Research Programs/Design for This Report

Table 117. Key Data Information from Secondary Sources

Table 118. Key Data Information from Primary Sources

Table 119. Authors List of This Report

List of Figures

Figure 1. Nuclear Medicine Picture

Figure 2. Global Nuclear Medicine Market Size Comparison by Type (US$ Million), 2021–2032

Figure 3. Global Nuclear Medicine Market Share by Type: 2025 vs 2032

Figure 4. Diagnostic Nuclear Medicine Features

Figure 5. Therapeutic Nuclear Medicine Features

Figure 6. Global Nuclear Medicine Market Size by Application (US$ Million), 2021–2032

Figure 7. Global Nuclear Medicine Market Share by Application: 2025 vs 2032

Figure 8. Oncology Case Studies

Figure 9. Thyroid Case Studies

Figure 10. Cardiology Case Studies

Figure 11. Others Case Studies

Figure 12. Nuclear Medicine Report Years Considered

Figure 13. Global Nuclear Medicine Market Size (US$ Million), Year-over-Year: 2021–2032

Figure 14. Global Nuclear Medicine Market Size, (US$ Million), 2021 vs 2025 vs 2032

Figure 15. Global Nuclear Medicine Market Share by Region: 2025 vs 2032

Figure 16. Global Nuclear Medicine Market Share by Players in 2025

Figure 17. Global Nuclear Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 18. The Top 10 and 5 Players Market Share by Nuclear Medicine Revenue in 2025

Figure 19. North America Nuclear Medicine Market Size YoY Growth (US$ Million), 2021–2032

Figure 20. North America Nuclear Medicine Market Share by Country (2021–2032)

Figure 21. United States Nuclear Medicine Market Size YoY Growth (US$ Million), 2021–2032

Figure 22. Canada Nuclear Medicine Market Size YoY Growth (US$ Million), 2021–2032

Figure 23. Europe Nuclear Medicine Market Size YoY Growth (US$ Million), 2021–2032

Figure 24. Europe Nuclear Medicine Market Share by Country (2021–2032)

Figure 25. Germany Nuclear Medicine Market Size YoY Growth (US$ Million), 2021–2032

Figure 26. France Nuclear Medicine Market Size YoY Growth (US$ Million), 2021–2032

Figure 27. U.K. Nuclear Medicine Market Size YoY Growth (US$ Million), 2021–2032

Figure 28. Italy Nuclear Medicine Market Size YoY Growth (US$ Million), 2021–2032

Figure 29. Russia Nuclear Medicine Market Size YoY Growth (US$ Million), 2021–2032

Figure 30. Ireland Nuclear Medicine Market Size YoY Growth (US$ Million), 2021–2032

Figure 31. Asia-Pacific Nuclear Medicine Market Size YoY Growth (US$ Million), 2021–2032

Figure 32. Asia-Pacific Nuclear Medicine Market Share by Region (2021–2032)

Figure 33. China Nuclear Medicine Market Size YoY Growth (US$ Million), 2021–2032

Figure 34. Japan Nuclear Medicine Market Size YoY Growth (US$ Million), 2021–2032

Figure 35. South Korea Nuclear Medicine Market Size YoY Growth (US$ Million), 2021–2032

Figure 36. Southeast Asia Nuclear Medicine Market Size YoY Growth (US$ Million), 2021–2032

Figure 37. India Nuclear Medicine Market Size YoY Growth (US$ Million), 2021–2032

Figure 38. Australia & New Zealand Nuclear Medicine Market Size YoY Growth (US$ Million), 2021–2032

Figure 39. Latin America Nuclear Medicine Market Size YoY Growth (US$ Million), 2021–2032

Figure 40. Latin America Nuclear Medicine Market Share by Country (2021–2032)

Figure 41. Mexico Nuclear Medicine Market Size YoY Growth (US$ Million), 2021–2032

Figure 42. Brazil Nuclear Medicine Market Size YoY Growth (US$ Million), 2021–2032

Figure 43. Middle East & Africa Nuclear Medicine Market Size YoY Growth (US$ Million), 2021–2032

Figure 44. Middle East & Africa Nuclear Medicine Market Share by Country (2021–2032)

Figure 45. Israel Nuclear Medicine Market Size YoY Growth (US$ Million), 2021–2032

Figure 46. Saudi Arabia Nuclear Medicine Market Size YoY Growth (US$ Million), 2021–2032

Figure 47. UAE Nuclear Medicine Market Size YoY Growth (US$ Million), 2021–2032

Figure 48. Cardinal Health Revenue Growth Rate in Nuclear Medicine Business (2021–2026)

Figure 49. GE Healthcare Revenue Growth Rate in Nuclear Medicine Business (2021–2026)

Figure 50. Jubilant Pharma Revenue Growth Rate in Nuclear Medicine Business (2021–2026)

Figure 51. Novartis Revenue Growth Rate in Nuclear Medicine Business (2021–2026)

Figure 52. Curium Pharma Revenue Growth Rate in Nuclear Medicine Business (2021–2026)

Figure 53. SIEMENS Revenue Growth Rate in Nuclear Medicine Business (2021–2026)

Figure 54. Lantheus Revenue Growth Rate in Nuclear Medicine Business (2021–2026)

Figure 55. Bracco Imaging Revenue Growth Rate in Nuclear Medicine Business (2021–2026)

Figure 56. Bayer Revenue Growth Rate in Nuclear Medicine Business (2021–2026)

Figure 57. Eli Lilly Revenue Growth Rate in Nuclear Medicine Business (2021–2026)

Figure 58. Aurobindo Pharma Revenue Growth Rate in Nuclear Medicine Business (2021–2026)

Figure 59. Mundipharma Revenue Growth Rate in Nuclear Medicine Business (2021–2026)

Figure 60. China Isotope & Radiation Revenue Growth Rate in Nuclear Medicine Business (2021–2026)

Figure 61. Yantai Dongcheng Revenue Growth Rate in Nuclear Medicine Business (2021–2026)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Radiopharmaceutical Market Research Report 2025

Global SPECT and PET Radiopharmaceuticals Market Research Report 2024

Global Radiopharmaceuticals in Nuclear Medicine Market Research Report 2025

Global Radiopharmaceutical Therapy Market Research Report 2025

Global Diagnostic Nuclear Medicines Market Insights Forecast to 2030

Global Radiopharmaceuticals for Diagnosis Market Research Report 2024

Global SPECT Radiopharmaceuticals Market Research Report 2025

Global Radioactive Therapeutic Drugs Market Research Report 2024

Global Radioisotopes in Medicine Market Research Report 2025

Global Diagnostic Radiopharmaceuticals Market Research Report 2024

Nuclear Medicine Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Medical Radioisotopes Market Research Report 2025

Global Diagnostic Radioisotopes Market Insights Forecast to 2030

Global Nuclear Medicine Radioisotopes Market Insights Forecast to 2030

Global Nuclear Medicine System Market Insights Forecast to 2030

Global Therapeutic Radiopharmaceuticals Market Insights Forecast to 2030

Radiopharmaceutical Theranostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global PET Radioisotope Radiopharmaceuticals in PET Imaging Market Research Report 2024

Global Therapeutic Radioisotopes Market Insights Forecast to 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions